XTLB 주가 차트
XTLB 주가 예측
XTL Biopharmaceuticals Ltd.
$2.73
4.59%
$0.12
종가: May 13, 16:00:00 GMT-4
$2.71
-0.41%
$-0.01
애프터마켓: May 13, 19:30:38 GMT-4
뒤로
XTL Biopharmaceuticals Ltd. (XTLB) 주가 예측
주요 통계
이전 종가
$2.61
시가
$2.63
일일 범위
$2.51 - $2.75
52주 범위
$2.12 - $10.28
거래량
20.6K
평균 거래량
1.9M
배당수익률
--
EPS(TTM)
-3.60
시가총액
$6.4M
XTL Biopharmaceuticals Ltd.란 무엇인가요?
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The firm pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong a survival of patients for treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by kidneys. EPO stimulates erythropoiesis, production of red blood cells, by binding to its receptor on a surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.
